• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: lymphoma

  • Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia
    • in Oncology · Video
    • — 19 Dec, 2013

    Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia

    NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblastic leukemia and otherwise had very short life expectancies. Stephan A Grupp, …

    Read more
    Audio Journal of Oncology Volume 16 Number 10
    • in Oncology
    • — 25 May, 2008

    Audio Journal of Oncology Volume 16 Number 10

    Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
    Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin

    In this edition Peter Goodwin and Sara Freeman report from:
    European Breast Cancer Conference, Berlin, April 15-19, 2008;
    Chemotherapy …

    Read more
  • Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
    • in General Medicine
    • — 27 Feb, 2008

    Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

    Timothy Illidge
    Timothy Illidge

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    TIMOTHY ILLIDGE, Christie Hospital, Manchester
    Radioconjugated antibodies are showing great promise for treating follicular lymphoma which has failed chemotherapy combined with rituximab. That’s according to Tim
    …
    Read more
    Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
    • in News · Oncology
    • — 26 Feb, 2008

    Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

    Martin Dreyling
    Martin Dreyling

    Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
    MARTIN DREYLING, University Hospital Grosshaden, Munich
    Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Ibritumomab Provides Benefit in Patients with Follicular Lymphoma

    Anton Hagenbeek
    Anton Hagenbeek

    ANTON HAGENBEEK, University Medical Centre Utrecht
    For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

    Christian Geisler
    Christian Geisler

    CHRISTIAN GEISLER, Rigshospitalet, Copenhagen
    Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details on the study – which featured an intensive immunochemotherapy
    …
    Read more
  • ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando
    • in ASCO · Oncology
    • — 3 Feb, 2007

    ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando

    Francis Giles
    Francis Giles
    Ken Kaushansky
    Ken Kaushansky
    Heather Leitch
    Heather Leitch
    Nancy Berliner
    Nancy Berliner
    Corrado Tarella
    Corrado Tarella
    Vincent Rajkumar
    Vincent Rajkumar
    Robert Kyle
    Robert Kyle

    Aurora Kinase BCR-ABL Inhibitor Beats T315-I Mutation in Patients with Chronic Myeloid Leukemia

    REFERENCE: Abstract: 163
    FRANCIS GILES, M D Anderson Cancer Center, Houston
    COMMENT: KEN

    …
    Read more
    ASCO Audio Journal of Oncology in Advance – December 15th, 2006 – Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006
    • in AJO · ASCO · Oncology
    • — 16 Dec, 2006

    ASCO Audio Journal of Oncology in Advance – December 15th, 2006 – Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006

    Martin Müller
    Martin Müller
    Charles Linker
    Charles Linker
    Andreas Hochhaus
    Andreas Hochhaus
    Christian Buske
    Christian Buske
    Katarina Le Blanc
    Katarina Le Blanc
    Stephen Emerson
    Stephen Emerson
    Alessandro Vannucchi
    Alessandro Vannucchi
    Kanti Rai
    Kanti Rai
    Richard Schlenk
    Richard Schlenk

    BCR-ABL Mutations After Imatinib Failure: Impact on Response to Dasatinib

    REFERENCE: American Society of Hematology 2006 Orlando: Abstract: 748
    MARTIN MÜLLER,

    …
    Read more
  • Audio Journal of Oncology in Advance – October 1st, 2006
    • in AJO · Oncology
    • — 1 Oct, 2006

    Audio Journal of Oncology in Advance – October 1st, 2006

    George Canellos
    George Canellos
    Sandra Strauss
    Sandra Strauss
    Nancy Baxter
    Nancy Baxter

    KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk
    Liver Metastasis Resection Not Curative for Colorectal Cancer
    Patients With Node Negative Breast Cancer: Low Risk After Mastectomy

    REFERENCES: J Clin Oncol 34:3904, 3927,

    …
    Read more
    Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma
    • in ASH 2005
    • — 21 Dec, 2005

    Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma

    Sandra Horning
    Sandra Horning

    Abstract 349
    Sandra Horning, Stanford University Medical Center
    It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therapy in patients with advanced follicular lymphoma. However, the use of rituximab maintenance, after induction …

    Read more
  • Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma
    • in ASH 2005
    • — 21 Dec, 2005

    Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma

    Owen O'Connor
    Owen O’Connor

    Owen O’Connor, Memorial Sloan-Kettering Cancer Center, New York
    Owen O’Connor also gave data from early, two studies: one looking at treating lymphoma with the drug SAHA which targets BCL-6 in the tumor preventing it’s anti-apoptotic influence; the other …

    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: lymphoma

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.